{
  "symbol": "MO",
  "year": 2022,
  "Period": "Q1",
  "report_type": "Q10",
  "metrics": {
    "mdna_sentiment": 0.0,
    "outlook_sentiment": 0.2169,
    "forward_ratio": 1.0,
    "hedge_ratio": 0.167
  },
  "top_positive": [
    {
      "sent": "48 Table of Contents The following table provides a reconciliation of adjusted net earnings attributable to Altria and adjusted diluted EPS attributable to Altria for the nine months ended September 30: (in millions of dollars, except per share data) Earnings (Losses) before Income Taxes Provision (Benefit) for Income Taxes Net Earnings (Losses) Net Earnings (Losses) Attributable to Altria Diluted EPS 2022 Reported $ 4,685 $ 1,611 $ 3,074 $ 3,074 $ 1.69 NPM Adjustment Items (60) (15) (45) (45) (0.02) Asset impairment, exit, implementation, acquisition and disposition-related costs 10 2 8 8 \u2014 Tobacco and health and certain other litigation items 101 25 76 76 0.04 JUUL changes in fair value 1,355 \u2014 1,355 1,355 0.76 ABI-related special items 2,560 538 2,022 2,022 1.12 Cronos-related special items 180 8 172 172 0.09 Income tax items \u2014 33 (33) (33) (0.02) 2022 Adjusted for Special Items $ 8,831 $ 2,202 $ 6,629 $ 6,629 $ 3.66 2021 Reported $ 1,544 $ 693 $ 851 $ 851 $ 0.46 NPM Adjustment Items (76) (19) (57) (57) (0.03) Asset impairment, exit, implementation, acquisition and disposition-related costs 117 22 95 95 0.05 Tobacco and health and certain other litigation items 148 35 113 113 0.06 ABI-related special items 6,111 1,283 4,828 4,828 2.60 Cronos-related special items 200 (5) 205 205 0.11 Loss on early extinguishment of debt 649 153 496 496 0.27 Income tax items \u2014 5 (5) (5) \u2014 2021 Adjusted for Special Items $ 8,693 $ 2,167 $ 6,526 $ 6,526 $ 3.52 49 Table of Contents The following table provides a reconciliation of adjusted net earnings attributable to Altria and adjusted diluted EPS attributable to Altria for the three months ended September 30: (in millions of dollars, except per share data) Earnings (Losses) before Income Taxes Provision (Benefit) for Income Taxes Net Earnings (Losses) Net Earnings (Losses) Attributable to Altria Diluted EPS 2022 Reported $ 407 $ 183 $ 224 $ 224 $ 0.12 Asset impairment, exit, implementation, acquisition and disposition-related costs 1 \u2014 1 1 \u2014 Tobacco and health and certain other litigation items 43 11 32 32 0.02 JUUL changes in fair value 100 \u2014 100 100 0.06 ABI-related special items 2,507 527 1,980 1,980 1.10 Cronos-related special items 5 \u2014 5 5 \u2014 Income tax items \u2014 42 (42) (42) (0.02) 2022 Adjusted for Special Items $ 3,063 $ 763 $ 2,300 $ 2,300 $ 1.28 2021 Reported $ (3,302) $ (582) $ (2,720) $ (2,722) $ (1.48) NPM Adjustment Items (44) (11) (33) (33) (0.02) Asset impairment, exit, implementation, acquisition and disposition-related costs 61 9 52 52 0.03 Tobacco and health and certain other litigation items 105 25 80 80 0.04 JUUL changes in fair value (100) \u2014 (100) (100) (0.05) ABI-related special items 6,200 1,301 4,899 4,899 2.65 Cronos-related special items 89 \u2014 89 89 0.05 Income tax items \u2014 8 (8) (8) \u2014 2021 Adjusted for Special Items $ 3,009 $ 750 $ 2,259 $ 2,257 $ 1.22 The following special items affected the comparability of statements of earnings (losses) amounts for the nine and three months ended September 30, 2022 and 2021: \u25aa NPM Adjustment Items: For a discussion of NPM Adjustment Items and a breakdown of these items by segment, see Health Care Cost Recovery Litigation in Note 11.",
      "score": 0.9948
    },
    {
      "sent": "48 Table of Contents The following table provides a reconciliation of adjusted net earnings attributable to Altria and adjusted diluted EPS attributable to Altria for the nine months ended September 30: (in millions of dollars, except per share data) Earnings (Losses) before Income Taxes Provision (Benefit) for Income Taxes Net Earnings (Losses) Net Earnings (Losses) Attributable to Altria Diluted EPS 2022 Reported $ 4,685 $ 1,611 $ 3,074 $ 3,074 $ 1.69 NPM Adjustment Items (60) (15) (45) (45) (0.02) Asset impairment, exit, implementation, acquisition and disposition-related costs 10 2 8 8 \u2014 Tobacco and health and certain other litigation items 101 25 76 76 0.04 JUUL changes in fair value 1,355 \u2014 1,355 1,355 0.76 ABI-related special items 2,560 538 2,022 2,022 1.12 Cronos-related special items 180 8 172 172 0.09 Income tax items \u2014 33 (33) (33) (0.02) 2022 Adjusted for Special Items $ 8,831 $ 2,202 $ 6,629 $ 6,629 $ 3.66 2021 Reported $ 1,544 $ 693 $ 851 $ 851 $ 0.46 NPM Adjustment Items (76) (19) (57) (57) (0.03) Asset impairment, exit, implementation, acquisition and disposition-related costs 117 22 95 95 0.05 Tobacco and health and certain other litigation items 148 35 113 113 0.06 ABI-related special items 6,111 1,283 4,828 4,828 2.60 Cronos-related special items 200 (5) 205 205 0.11 Loss on early extinguishment of debt 649 153 496 496 0.27 Income tax items \u2014 5 (5) (5) \u2014 2021 Adjusted for Special Items $ 8,693 $ 2,167 $ 6,526 $ 6,526 $ 3.52 49 Table of Contents The following table provides a reconciliation of adjusted net earnings attributable to Altria and adjusted diluted EPS attributable to Altria for the three months ended September 30: (in millions of dollars, except per share data) Earnings (Losses) before Income Taxes Provision (Benefit) for Income Taxes Net Earnings (Losses) Net Earnings (Losses) Attributable to Altria Diluted EPS 2022 Reported $ 407 $ 183 $ 224 $ 224 $ 0.12 Asset impairment, exit, implementation, acquisition and disposition-related costs 1 \u2014 1 1 \u2014 Tobacco and health and certain other litigation items 43 11 32 32 0.02 JUUL changes in fair value 100 \u2014 100 100 0.06 ABI-related special items 2,507 527 1,980 1,980 1.10 Cronos-related special items 5 \u2014 5 5 \u2014 Income tax items \u2014 42 (42) (42) (0.02) 2022 Adjusted for Special Items $ 3,063 $ 763 $ 2,300 $ 2,300 $ 1.28 2021 Reported $ (3,302) $ (582) $ (2,720) $ (2,722) $ (1.48) NPM Adjustment Items (44) (11) (33) (33) (0.02) Asset impairment, exit, implementation, acquisition and disposition-related costs 61 9 52 52 0.03 Tobacco and health and certain other litigation items 105 25 80 80 0.04 JUUL changes in fair value (100) \u2014 (100) (100) (0.05) ABI-related special items 6,200 1,301 4,899 4,899 2.65 Cronos-related special items 89 \u2014 89 89 0.05 Income tax items \u2014 8 (8) (8) \u2014 2021 Adjusted for Special Items $ 3,009 $ 750 $ 2,259 $ 2,257 $ 1.22 The following special items affected the comparability of statements of earnings (losses) amounts for the nine and three months ended September 30, 2022 and 2021: \u25aa NPM Adjustment Items: For a discussion of NPM Adjustment Items and a breakdown of these items by segment, see Health Care Cost Recovery Litigation in Note 11.",
      "score": 0.9948
    },
    {
      "sent": "42 Table of Contents Consolidated Results of Operations for the Three Months Ended September 30, 2022 The changes in net earnings (losses) attributable to Altria and diluted EPS attributable to Altria for the three months ended September 30, 2022, from the three months ended September 30, 2021, were due primarily to the following: (in millions, except per share data) Net Earnings (Losses) Diluted EPS For the three months ended September 30, 2021 $ (2,722) $ (1.48) 2021 NPM Adjustment Items (33) (0.02) 2021 Asset impairment, exit, implementation, acquisition and disposition-related costs 52 0.03 2021 Tobacco and health and certain other litigation items 80 0.04 2021 JUUL changes in fair value (100) (0.05) 2021 ABI-related special items 4,899 2.65 2021 Cronos-related special items 89 0.05 2021 Income tax items (8) \u2014 Subtotal 2021 special items 4,979 2.70 2022 Asset impairment, exit, implementation, acquisition and disposition-related costs (1) \u2014 2022 Tobacco and health and certain other litigation items (32) (0.02) 2022 JUUL changes in fair value (100) (0.06) 2022 ABI-related special items (1,980) (1.10) 2022 Cronos-related special items (5) \u2014 2022 Income tax items 42 0.02 Subtotal 2022 special items (2,076) (1.16) Fewer shares outstanding \u2014 0.03 Change in tax rate 1 \u2014 Operations 42 0.03 For the three months ended September 30, 2022 $ 224 $ 0.12 2022 Reported Net Earnings (Losses) $ 224 $ 0.12 2021 Reported Net Earnings (Losses) $ (2,722) $ (1.48) % Change 100%+ 100%+ 2022 Adjusted Net Earnings and Adjusted Diluted EPS $ 2,300 $ 1.28 2021 Adjusted Net Earnings and Adjusted Diluted EPS $ 2,257 $ 1.22 % Change 1.9 % 4.9 % For a discussion of special items and other business drivers affecting the comparability of statements of earnings (losses) amounts and reconciliations of adjusted earnings attributable to Altria and adjusted diluted EPS attributable to Altria, see the Consolidated Operating Results section below.",
      "score": 0.9893
    }
  ],
  "top_negative": [
    {
      "sent": "Various types of claims may be raised in these proceedings, including product liability, unfair trade practices, antitrust, income tax liability, contraband shipments, patent infringement, employment matters, claims alleging violation of the Racketeer Influenced and Corrupt Organizations Act (\u201cRICO\u201d), claims for contribu\ny extinguishment of debt of $ 649 million, which included premiums and fees of $ 623 million and the write-off of unamortized debt discounts and debt issuance costs of $ 26 million.",
      "score": -0.9545
    },
    {
      "sent": "(4) Includes as of October 24, 2022, one inactive smoking and health case alleging personal injury and purporting to be brought on behalf of a class of individual plaintiffs and two inactive class action lawsuits alleging that use of the terms \u201cLights\u201d and \u201cUltra Lights\u201d constitute deceptive and unfair trade practices, common law or statutory fraud, unjust enrichment, breach of warranty or violations of RICO.",
      "score": -0.9517
    },
    {
      "sent": "(4) Includes as of October 24, 2022, one inactive smoking and health case alleging personal injury and purporting to be brought on behalf of a class of individual plaintiffs and two inactive class action lawsuits alleging that use of the terms \u201cLights\u201d and \u201cUltra Lights\u201d constitute deceptive and unfair trade practices, common law or statutory fraud, unjust enrichment, breach of warranty or violations of RICO.",
      "score": -0.9517
    }
  ],
  "forward_snippets": [
    "This guidance simplifies the accounting for certain financial 11 Table of Contents instruments with characteristics of liabilities and equity, including convertible instruments and contracts in an entity\u2019s own equity.",
    "For a description of issued accounting guidance applicable to, but not yet adopted by, us, see Note 12.",
    "New Accounting Guidance Not Yet Adopted .",
    "This guidance simplifies the accounting for certain financial 11 Table of Contents instruments with characteristics of liabilities and equity, including convertible instruments and contracts in an entity\u2019s own equity.",
    "For a description of issued accounting guidance applicable to, but not yet adopted by, us, see Note 12."
  ],
  "curated_text": "Symbol: MO. Year: 2022. Period: Q1. ReportType: Q10. Section: Management Discussion and Analysis (MD&A). Key metrics include sentiment, forward outlook, and risk hedging.  Top positive sentences: 48 Table of Contents The following table provides a reconciliation of adjusted net earnings attributable to Altria and adjusted diluted EPS attributable to Altria for the nine months ended September 30: (in millions of dollars, except per share data) Earnings (Losses) before Income Taxes Provision (Benefit) for Income Taxes Net Earnings (Losses) Net Earnings (Losses) Attributable to Altria Diluted EPS 2022 Reported $ 4,685 $ 1,611 $ 3,074 $ 3,074 $ 1.69 NPM Adjustment Items (60) (15) (45) (45) (0.02) Asset impairment, exit, implementation, acquisition and disposition-related costs 10 2 8 8 \u2014 Tobacco and health and certain other litigation items 101 25 76 76 0.04 JUUL changes in fair value 1,355 \u2014 1,355 1,355 0.76 ABI-related special items 2,560 538 2,022 2,022 1.12 Cronos-related special items 180 8 172 172 0.09 Income tax items \u2014 33 (33) (33) (0.02) 2022 Adjusted for Special Items $ 8,831 $ 2,202 $ 6,629 $ 6,629 $ 3.66 2021 Reported $ 1,544 $ 693 $ 851 $ 851 $ 0.46 NPM Adjustment Items (76) (19) (57) (57) (0.03) Asset impairment, exit, implementation, acquisition and disposition-related costs 117 22 95 95 0.05 Tobacco and health and certain other litigation items 148 35 113 113 0.06 ABI-related special items 6,111 1,283 4,828 4,828 2.60 Cronos-related special items 200 (5) 205 205 0.11 Loss on early extinguishment of debt 649 153 496 496 0.27 Income tax items \u2014 5 (5) (5) \u2014 2021 Adjusted for Special Items $ 8,693 $ 2,167 $ 6,526 $ 6,526 $ 3.52 49 Table of Contents The following table provides a reconciliation of adjusted net earnings attributable to Altria and adjusted diluted EPS attributable to Altria for the three months ended September 30: (in millions of dollars, except per share data) Earnings (Losses) before Income Taxes Provision (Benefit) for Income Taxes Net Earnings (Losses) Net Earnings (Losses) Attributable to Altria Diluted EPS 2022 Reported $ 407 $ 183 $ 224 $ 224 $ 0.12 Asset impairment, exit, implementation, acquisition and disposition-related costs 1 \u2014 1 1 \u2014 Tobacco and health and certain other litigation items 43 11 32 32 0.02 JUUL changes in fair value 100 \u2014 100 100 0.06 ABI-related special items 2,507 527 1,980 1,980 1.10 Cronos-related special items 5 \u2014 5 5 \u2014 Income tax items \u2014 42 (42) (42) (0.02) 2022 Adjusted for Special Items $ 3,063 $ 763 $ 2,300 $ 2,300 $ 1.28 2021 Reported $ (3,302) $ (582) $ (2,720) $ (2,722) $ (1.48) NPM Adjustment Items (44) (11) (33) (33) (0.02) Asset impairment, exit, implementation, acquisition and disposition-related costs 61 9 52 52 0.03 Tobacco and health and certain other litigation items 105 25 80 80 0.04 JUUL changes in fair value (100) \u2014 (100) (100) (0.05) ABI-related special items 6,200 1,301 4,899 4,899 2.65 Cronos-related special items 89 \u2014 89 89 0.05 Income tax items \u2014 8 (8) (8) \u2014 2021 Adjusted for Special Items $ 3,009 $ 750 $ 2,259 $ 2,257 $ 1.22 The following special items affected the comparability of statements of earnings (losses) amounts for the nine and three months ended September 30, 2022 and 2021: \u25aa NPM Adjustment Items: For a discussion of NPM Adjustment Items and a breakdown of these items by segment, see Health Care Cost Recovery Litigation in Note 11. 48 Table of Contents The following table provides a reconciliation of adjusted net earnings attributable to Altria and adjusted diluted EPS attributable to Altria for the nine months ended September 30: (in millions of dollars, except per share data) Earnings (Losses) before Income Taxes Provision (Benefit) for Income Taxes Net Earnings (Losses) Net Earnings (Losses) Attributable to Altria Diluted EPS 2022 Reported $ 4,685 $ 1,611 $ 3,074 $ 3,074 $ 1.69 NPM Adjustment Items (60) (15) (45) (45) (0.02) Asset impairment, exit, implementation, acquisition and disposition-related costs 10 2 8 8 \u2014 Tobacco and health and certain other litigation items 101 25 76 76 0.04 JUUL changes in fair value 1,355 \u2014 1,355 1,355 0.76 ABI-related special items 2,560 538 2,022 2,022 1.12 Cronos-related special items 180 8 172 172 0.09 Income tax items \u2014 33 (33) (33) (0.02) 2022 Adjusted for Special Items $ 8,831 $ 2,202 $ 6,629 $ 6,629 $ 3.66 2021 Reported $ 1,544 $ 693 $ 851 $ 851 $ 0.46 NPM Adjustment Items (76) (19) (57) (57) (0.03) Asset impairment, exit, implementation, acquisition and disposition-related costs 117 22 95 95 0.05 Tobacco and health and certain other litigation items 148 35 113 113 0.06 ABI-related special items 6,111 1,283 4,828 4,828 2.60 Cronos-related special items 200 (5) 205 205 0.11 Loss on early extinguishment of debt 649 153 496 496 0.27 Income tax items \u2014 5 (5) (5) \u2014 2021 Adjusted for Special Items $ 8,693 $ 2,167 $ 6,526 $ 6,526 $ 3.52 49 Table of Contents The following table provides a reconciliation of adjusted net earnings attributable to Altria and adjusted diluted EPS attributable to Altria for the three months ended September 30: (in millions of dollars, except per share data) Earnings (Losses) before Income Taxes Provision (Benefit) for Income Taxes Net Earnings (Losses) Net Earnings (Losses) Attributable to Altria Diluted EPS 2022 Reported $ 407 $ 183 $ 224 $ 224 $ 0.12 Asset impairment, exit, implementation, acquisition and disposition-related costs 1 \u2014 1 1 \u2014 Tobacco and health and certain other litigation items 43 11 32 32 0.02 JUUL changes in fair value 100 \u2014 100 100 0.06 ABI-related special items 2,507 527 1,980 1,980 1.10 Cronos-related special items 5 \u2014 5 5 \u2014 Income tax items \u2014 42 (42) (42) (0.02) 2022 Adjusted for Special Items $ 3,063 $ 763 $ 2,300 $ 2,300 $ 1.28 2021 Reported $ (3,302) $ (582) $ (2,720) $ (2,722) $ (1.48) NPM Adjustment Items (44) (11) (33) (33) (0.02) Asset impairment, exit, implementation, acquisition and disposition-related costs 61 9 52 52 0.03 Tobacco and health and certain other litigation items 105 25 80 80 0.04 JUUL changes in fair value (100) \u2014 (100) (100) (0.05) ABI-related special items 6,200 1,301 4,899 4,899 2.65 Cronos-related special items 89 \u2014 89 89 0.05 Income tax items \u2014 8 (8) (8) \u2014 2021 Adjusted for Special Items $ 3,009 $ 750 $ 2,259 $ 2,257 $ 1.22 The following special items affected the comparability of statements of earnings (losses) amounts for the nine and three months ended September 30, 2022 and 2021: \u25aa NPM Adjustment Items: For a discussion of NPM Adjustment Items and a breakdown of these items by segment, see Health Care Cost Recovery Litigation in Note 11. 42 Table of Contents Consolidated Results of Operations for the Three Months Ended September 30, 2022 The changes in net earnings (losses) attributable to Altria and diluted EPS attributable to Altria for the three months ended September 30, 2022, from the three months ended September 30, 2021, were due primarily to the following: (in millions, except per share data) Net Earnings (Losses) Diluted EPS For the three months ended September 30, 2021 $ (2,722) $ (1.48) 2021 NPM Adjustment Items (33) (0.02) 2021 Asset impairment, exit, implementation, acquisition and disposition-related costs 52 0.03 2021 Tobacco and health and certain other litigation items 80 0.04 2021 JUUL changes in fair value (100) (0.05) 2021 ABI-related special items 4,899 2.65 2021 Cronos-related special items 89 0.05 2021 Income tax items (8) \u2014 Subtotal 2021 special items 4,979 2.70 2022 Asset impairment, exit, implementation, acquisition and disposition-related costs (1) \u2014 2022 Tobacco and health and certain other litigation items (32) (0.02) 2022 JUUL changes in fair value (100) (0.06) 2022 ABI-related special items (1,980) (1.10) 2022 Cronos-related special items (5) \u2014 2022 Income tax items 42 0.02 Subtotal 2022 special items (2,076) (1.16) Fewer shares outstanding \u2014 0.03 Change in tax rate 1 \u2014 Operations 42 0.03 For the three months ended September 30, 2022 $ 224 $ 0.12 2022 Reported Net Earnings (Losses) $ 224 $ 0.12 2021 Reported Net Earnings (Losses) $ (2,722) $ (1.48) % Change 100%+ 100%+ 2022 Adjusted Net Earnings and Adjusted Diluted EPS $ 2,300 $ 1.28 2021 Adjusted Net Earnings and Adjusted Diluted EPS $ 2,257 $ 1.22 % Change 1.9 % 4.9 % For a discussion of special items and other business drivers affecting the comparability of statements of earnings (losses) amounts and reconciliations of adjusted earnings attributable to Altria and adjusted diluted EPS attributable to Altria, see the Consolidated Operating Results section below. Top negative sentences: Various types of claims may be raised in these proceedings, including product liability, unfair trade practices, antitrust, income tax liability, contraband shipments, patent infringement, employment matters, claims alleging violation of the Racketeer Influenced and Corrupt Organizations Act (\u201cRICO\u201d), claims for contribu\ny extinguishment of debt of $ 649 million, which included premiums and fees of $ 623 million and the write-off of unamortized debt discounts and debt issuance costs of $ 26 million. (4) Includes as of October 24, 2022, one inactive smoking and health case alleging personal injury and purporting to be brought on behalf of a class of individual plaintiffs and two inactive class action lawsuits alleging that use of the terms \u201cLights\u201d and \u201cUltra Lights\u201d constitute deceptive and unfair trade practices, common law or statutory fraud, unjust enrichment, breach of warranty or violations of RICO. (4) Includes as of October 24, 2022, one inactive smoking and health case alleging personal injury and purporting to be brought on behalf of a class of individual plaintiffs and two inactive class action lawsuits alleging that use of the terms \u201cLights\u201d and \u201cUltra Lights\u201d constitute deceptive and unfair trade practices, common law or statutory fraud, unjust enrichment, breach of warranty or violations of RICO. Forward-looking snippets: This guidance simplifies the accounting for certain financial 11 Table of Contents instruments with characteristics of liabilities and equity, including convertible instruments and contracts in an entity\u2019s own equity. For a description of issued accounting guidance applicable to, but not yet adopted by, us, see Note 12. New Accounting Guidance Not Yet Adopted . This guidance simplifies the accounting for certain financial 11 Table of Contents instruments with characteristics of liabilities and equity, including convertible instruments and contracts in an entity\u2019s own equity. For a description of issued accounting guidance applicable to, but not yet adopted by, us, see Note 12."
}